Story perspectives

Protein Therapeutics Market Set to Hit $558.95 Billion by 2032

8/30/2025

Summary

Story summary

The global protein therapeutics market is expected to grow at a 7.1% CAGR, reaching USD 558.95 billion by 2032, due to chronic diseases and monoclonal antibody demand.
High protein therapy costs limit access in low- and middle-income regions.
The EU's new HTA Regulation seeks to improve health technology evaluations and therapy availability.
AI advancements are enhancing drug discovery and protein design, improving treatment precision and reducing costs.
Grifols is utilizing AI to innovate in biopharma medicine development.

History

Historical Context

The Biologics Control Act of 1902 established essential safety standards for protein therapeutics in the U.S., paving the way for innovations like monoclonal antibodies. Today, the global protein therapeutics market is projected to reach USD 558.95 billion by 2032, driven by chronic diseases and advancements in AI, which enhance drug discovery and accessibility, especially in low- and middle-income regions.

1 of 2

Story summary

The global protein therapeutics market is expected to grow at a 7.1% CAGR, reaching USD 558.95 billion by 2032, due to chronic diseases and monoclonal antibody demand.
High protein therapy costs limit access in low- and middle-income regions.
The EU's new HTA Regulation seeks to improve health technology evaluations and therapy availability.
AI advancements are enhancing drug discovery and protein design, improving treatment precision and reducing costs.
Grifols is utilizing AI to innovate in biopharma medicine development.

1 / 2